References
- Fukuoka M., Niitani H., Suzuki A., Motomiya M., Hasegawa K., Nishiwaki Y., Kuriyama T., Ariyoshi Y., Nagoro S., Masuda N., Nakajima S., Taguchi T. A phase II study of CPT-11, a new derivative of Camptothecin, for previously untreated non-small-cell lung cancer. Journal of Clinical Oncology 1992; 10: 16–20
- Hakusui H., Suzuki W., Atsumi R. Studies on the metabolic fate of CPT-11 (3): Pharmacokinetics in rats following a single intravenous administration of 14C-CPT-11 (pp). Yakubutudoutai 1991; 6: 105–126
- Hosoya E. Scientific reevaluation of Kampo prescriptions using modern technology. Recent Advances in the Pharmacology of KAMPO (Japanese Herbal) Medicines, E. Hosoya, Y. Yamamura. Excerpta Medica, Tokyo 1988; 17–29
- Kaneda N., Yokokura T. Nonlinear pharmacokinetics of CPT-11 in rats. Cancer Research 1990; 50: 1721–1725
- Kaneda N., Nagata H., Furuta T., Yokokura T. Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse. Cancer Researc 1990; 50: 1715–1720
- Kunimoto T., Nitta K., Tanaka T., Uehara N., Baba H., Takeuchi M., Yokokura T., Sawada S., Miyasaka T., Mutai M. Antitumor activity of 7-ethyl-10-[4-(1-piperidino)1- piperidino]carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin, against murine tumors. Cancer Research 1987; 47: 5944–5947
- Levvy G. A., Conchie J. β-Glururonidase and the hydrolysis of glucuronides. Glucuronic Acid, G. J. Dutton. Academic Press, New York 1966; 301–364
- Miyasaka T., Mutai M., Sawada S., Nokata K., Hagiwara H. Synthesis of new camptothecin derivatives. Japanese Patent 1981; 56–158786
- Mulder G. J., Coughtrie M. W. H., Burchell B. Glucuronidation. Conjugation reactions in drug metabolism, G. J. Mulder. Taylor & Francis, London 1990; 51–105
- Ohno R., Okada K., Masaoka T., Kuramoto A., Arima T., Yoshida Y., Ariyoshi H., Ichimaru M., Sakai Y., Oruro M., Ito Y., Morishima Y., Yokomaku S., Ota K. An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma. Journal of Clinical Oncology 1990; 8: 1907–1912
- Suzuki W., Atsumi R., Hakusui H. Studies on the metabolic fate of CPT-11 (2), Pharmacokinetics in rats following a single intravenous dose (2), metabolites pattern in serum, liver, kidney and intestinal tissue. Yakubutudoutai 1991; 6: 97–104
- Taguchi T., Wakui A., Hasegawa K., Niitani H., Furue H., Ohta K., Hattori T. Phase I clinical study of CPT-11. Japanese Journal of Cancer Chemotherapy 1990; 17: 115–120
- Wall M. E., Wani M. C., Cook C. E., Palmer Mc K. H., Phail A. T., Sim G. A. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from. Camptotheca acuminata. Journal of the American Chemical Society 1966; 88: 3888–3890
- Wallemacq P. E., Lesne M. New automatic high-performance liquid chromatographic analysis of cyclosporin A and G in human serum. Journal of Chromatography 1987; 413: 131–140